Adamis Pharmaceuticals (ADMP) Prices $6.7M Registered Direct Offering

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/14/2026

1. DPZ
2. NVDA
3. GS
4. BAC
5. DRS
6. AVAV
7. ACI
8. UNH
9. ORCL
10. JPM

Go back to Adamis Pharmaceuticals (ADMP) Prices $6.7M Registered Direct Offering

Adamis Pharmaceuticals Announces Pricing of $6.7 Million Registered Direct Offering

February 21, 2020 9:15 AM EST

SAN DIEGO, Feb. 21, 2020 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) (Adamis or the Company) today announced it has entered into a securities purchase agreement with certain accredited institutional investors to purchase approximately $6.7 million of its common stock in a registered direct offering and warrants to purchase shares of common stock in a concurrent private placement.  The combined purchase price for one share of common stock and 0.75 warrants will be $0.58.

Under the terms of the purchase agreement, Adamis has agreed to sell 11,600,000 shares of its common stock.  In a concurrent private placement,... More